NCT03361826
- Conditions
- Behavior, Behavioral Symptoms, Borderline Personality Disorder, +10 more
- Locations
-
- Centre for Addiction and Mental Health Toronto, Ontario, Canada
Clinical trial condition
Maple syrup urine disease, type 2
Explore clinical trials studying Maple syrup urine disease, type 2. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Maple syrup urine disease, type 2 trial results
NCT01547052
- Conditions
- Behavior, Childhood Aggression, Emotional Regulation, +4 more
- Locations
-
- Green Chimneys Residential Treatment Center Brewster, New York, United States
Active, Not Recruiting
Early Check: Expanded Screening in Newborns
NCT03655223
- Conditions
- 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
- Locations
-
- RTI International Research Triangle Park, North Carolina, United States
Related conditions
- Behavior (2)
- Mental Disorders (2)
- 17 Alpha-Hydroxylase Deficiency (1)
- 3-Hydroxy-3-Methylglutaric Aciduria (1)
- 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)
- 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (1)
- 3-Methylcrotonyl CoA Carboxylase 1 Deficiency (1)
- 3-Methylcrotonyl CoA Carboxylase 2 Deficiency (1)